Description:
Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes.
- Molecular Weight:472.553
- Melting Point:190-196°C
- Purity:0.99
Molecular Formula:
C25H28N8O2
Canonical SMILES:
CC4=NC5=CC=CC=C5C(=N4)C)C
InChI:
InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1
InChIKey:
LTXREWYXXSTFRX-QGZVFWFLSA-N
Appearance:
Off-White to Yellowish Orange Solid
Application:
the treatment of type 2 diabetes
Synonyms:
Tradjenta; BI-1356; BI 1356; BI1356; Ondero; Trajenta Más detalles se encuentran
aquí